Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Cash from Financing Activities (2022 - 2025)

GE HealthCare Technologies' Cash from Financing Activities history spans 4 years, with the latest figure at -$293.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 77.06% year-over-year to -$293.0 million, compared with a TTM value of $617.0 million through Dec 2025, up 207.68%, and an annual FY2025 reading of $617.0 million, up 207.68% over the prior year.
  • Cash from Financing Activities for Q4 2025 was -$293.0 million at GE HealthCare Technologies, down from -$165.0 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $1.4 billion in Q2 2025, with the low at -$1.3 billion in Q4 2024.
  • Average Cash from Financing Activities over 4 years is -$78.5 million, with a median of -$159.0 million recorded in 2024.
  • Year-over-year, Cash from Financing Activities tumbled 2332.43% in 2023 and then soared 3908.33% in 2024.
  • Tracing GEHC's Cash from Financing Activities over 4 years: stood at -$37.0 million in 2022, then tumbled by 2332.43% to -$900.0 million in 2023, then tumbled by 41.89% to -$1.3 billion in 2024, then skyrocketed by 77.06% to -$293.0 million in 2025.
  • Per Business Quant, the three most recent readings for GEHC's Cash from Financing Activities are -$293.0 million (Q4 2025), -$165.0 million (Q3 2025), and $1.4 billion (Q2 2025).